CRUK Consent Forms – Bladder cancer immunotherapy regimens

Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website.

A new form for Nivolumab has been added.

Revalidation of the remaining regimen specific consent forms are in progress and will be updated in due course.

All forms can be found at www.cruk.org/sact_consent.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article
By BOPA Research Subcommittee on 16th April 2025

HSRPP workshop on conference abstracts

On behalf of the HSRPP Committee, Pharmacy Research UK are delighted to be hosting an online workshop on how to craft a good conference abstract. We will be covering points…

Read article
By BOPA on 14th April 2025

My Research Webinar – New Models of Care

The BOPA Research Subcommittee would like to invite you to one of our live webinar sessions on “New Models of Care”.   Webinar Schedule: Airedale NHS Foundation Trust secured NHSE…

Read article